Search results
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have...
Benzinga· 3 days agoEli Lilly And Co LLY “could be on its way to becoming a $1 trillion market cap company,” according...
Eli Lilly (LLY) Tops Q1 Earnings Estimates
Zacks via Yahoo Finance· 4 days agoLilly (LLY) delivered earnings and revenue surprises of 1.98% and 0.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Why Eli Lilly Stock Is Jumping Today
Motley Fool via Yahoo Finance· 4 days agoShares of Eli Lilly and Company (NYSE: LLY) were jumping 6% higher as of 11:03 a.m. ET on Tuesday. The solid gain came after the big drugmaker announced...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
NBC Bay Area· 4 days agoEli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance on strong sales of ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 4 days agoLilly said it expects significant production increases in the second half of the year for its...
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoBy almost any measure, Eli Lilly (NYSE: LLY) stock has been a standout so far in 2024. Using a basic...
Novo Nordisk, Eli Lilly drop on Amgen competition concerns By Investing.com
Investing.com· 1 day agoShares of Novo Nordisk (NYSE:NVO) and Eli Lilly & Co. (NYSE:LLY) are down premarket Friday as competition in the GLP-1 market. Amgen (NASDAQ:AMGN) disclosed ...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
WMBD - FOX 43 Peoria· 4 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024 - WTOP News
WTOP Washington· 4 days agoNEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Tuesday: Eli Lilly and Co., up $43.90 to $781.10. The drugmaker raised its profit forecast for the year. 3M Co., up $4.
Eli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and Raises Full-Year Guidance
GuruFocus.com via Yahoo Finance· 4 days agoKey Product Performance: Mounjaro and Zepbound led revenue growth, with Mounjaro alone generating...
